The Victorian Connected Health Innovation and Commercialisation Centre (CHICC), powered by ANDHealth, was formally opened today by the Minister for Industry and Innovation, The Hon Ben Carroll MP.

The Victorian Government has invested $2.4 million towards the establishment of the CHICC, which will engage over 500 participants per year and bring together innovators, industry leaders, healthcare professionals, and investors to collaborate, connect and access free services and support.

ANDHealth CEO Bronwyn Le Grice said, “We have seen a remarkable 84% increase in the number of digital health companies in Victoria since June 2020, indicating the huge potential of the Victorian digital and connected health sector to drive new, high value jobs and better health outcomes.”  

Delivered by ANDHealth, Australia’s leading digital health commercialisation organisation, the CHICC's launch is a significant step forward for Victoria's digital health ecosystem.

“The opening of this hub is a major milestone in continuing to support the growth of Victoria's digital health ecosystem, providing vital resources and expertise to help these companies commercialise their world leading technologies, products and services for the benefit of patients in Australia and around the world,” said Ms Le Grice.

Two leading Victorian connected health companies expected to benefit from the centre are Macuject and Atmo Biosciences, who joined the launch to discuss their products.

Macuject was founded by Dr. Devinder Chauhan to meet the demand for consistent, high-quality eye injection care to a larger number of patients in his bulk-billing clinic located in Boronia, Victoria.

Macuject’s AI analyses macular OCT scans in the cloud, detecting and measuring abnormalities that would lead to preventable blindness without treatment.  

Atmo Biosciences is a digital health business developing an ingestible gas-sensing capsule.  Atmo’s gas-sensing capsule continuously measures clinically important gaseous biomarkers as it travels through the gut.  

Atmo’s ingestible Atmo Gas Capsule detects gases from known locations in the human gut and wirelessly transmits data to help medical professionals better diagnose functional gastrointestinal disorders.

‍